Substances · Cannabinoids (Indazole carboxamides)
MDMB-4en-PINACA
- Preferred name
- MDMB-4en-PINACA
- IUPAC name
- methyl (2S)-3,3-dimethyl-2-[(1-pent-4-enylindazole-3-carbonyl)amino]butanoate
- Parent CAS number (reference)
- 2504100-70-1
- Molecular formula
- C20H27N3O3
- Molecular weight
- 357.4 g/mol
- InChIKey
- LWOCBHBFWNGPGM-QGZVFWFLSA-N
- PubChem
- CID 155804661
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
4en-PINACA MDMB4enPINACA MDMB 4en PINACA
Verified Neurochemical & Toxicological Intelligence
MDMB-4en-PINACA (4en-PINACA / 5-CL-ADB-A)
Receptor Telemetry & Mechanism of Action
Potent, efficacious **full agonist** at human CB1 receptors (Ki = 3.26 ± 0.81 nM in HEK cells; functional EC50 = 4.3 nM), replacing the 5-fluoropentyl tail of 5F-MDMB-PINACA with a terminal pent-4-en-1-yl alkene. The methyl 3,3-dimethylbutanoate ('MDMB') head moiety confers high CB1 potency and toxicity without THC's partial-agonist ceiling, interfering with hippocampal cognitive function and triggering heavy sedation or stimulation, dissociation, memory loss, agitation, and potentially fatal toxicity.
Biotransformation & Active Metabolites
Has an in vitro microsomal half-life of ~10 minutes, generating 14 metabolites; authentic human urine analyses identify dihydrodiol metabolite M3 (C19H27N3O5) and the ester-hydrolysis butanoic acid metabolite as primary biomarkers.
Temporal Pharmacokinetics
Rapid, overwhelmingly dense full-CB1 intoxication that shifts across a tiny microgram margin from cannabis-like mood elevation into dissociation, memory loss, confusion, agitation, or fatal coma.
- Onset 1–3 minutes inhaled (longer if swallowed)
- Peak Window 10–30 minutes inhaled
- Total Window 1–2 hours inhaled (up to 5–6 hours depending on amount and route)
- Residual / Half-Life 1–4 hours of cognitive fog and fatigue; in vitro t1/2 is ~10 minutes, with urinary metabolites detected within 1 hour.
EXTREME MICROGRAM HAZARD: WHO 43rd ECDD notes that the exact human pharmacological dose is unestablished, and EMCDDA stresses there is no antidote. Anchored to its 4.3 nM CB1 EC50 and WHO's 50 ug 5F-ADB benchmark, a single visible 1 mg (1,000 ug) speck of pure powder represents **multiple strong/overdose exposures**—making eyeballing potentially fatal and requiring strict volumetric liquid dilution.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
25–50 ug (0.025–0.05 mg — tentative microgram estimate)
Subtle perceptual softening, mild mood shift, and early time-sense slowing.
Faint bodily warmth and slight pulse shift.
50–100 ug (0.05–0.10 mg — tentative microgram estimate)
Cannabis-like mood elevation, sensory enhancement, and relaxed or mildly stimulated state.
Dry mouth, conjunctival redness, and mild motor slowing.
100–250 ug (0.10–0.25 mg — tentative microgram estimate)
Intense cannabimimetic intoxication, time dilation, short-term memory loss, and early dissociation.
Marked sedation (or paradoxical stimulation), tachycardia, impaired balance, and dizziness.
250–400 ug (0.25–0.40 mg — tentative microgram estimate)
Pronounced dissociation, confusion, agitation, acute anxiety/paranoia, and memory blackouts.
Severe ataxia, nausea/vomiting, chest pounding, and tremors.
400–500+ ug (0.40–0.50+ mg — tentative microgram estimate)
Loss of consciousness/coma, severe delirium, acute psychosis, and complete amnesia.
Vomiting with aspiration hazard, seizures, cardiovascular/renal toxicity, and documented fatal overdose.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
WHO 43rd ECDD flags adulteration/co-exposure with opioids (fentanyl/heroin); combining full CB1 stupor and vomiting with CNS depressants causes fatal respiratory arrest and aspiration.
Published post-mortem toxicology confirms dual-SCRA fatal overdoses from unpredictable full-CB1 cardiorespiratory collapse.
Co-detected in forensic cases; compounds tachycardia, seizures, and acute psychotic delirium.
Elevated Hazard — Avoid
Escalates severe dissociation, panic, confusion, and seizure susceptibility.
Caution / Receptor Attenuation
Never apply to or combine with cannabis flower—overrides THC's partial-agonist safety ceiling.
Structural Isomer & Sibling Comparison
MDMB-4en-PINACA (CB1 Ki = 3.26 nM, EC50 = 4.3 nM, alkene tail) is ~7-fold higher in numeric EC50 (less potent in vitro) than fluorinated 5F-MDMB-PINACA (EC50 0.59 nM) and ADB-PINACA (EC50 0.52 nM), while slightly more potent in EC50 than ADB-BUTINACA (EC50 6.36–11.5 nM) and beta-arrestin assays of 4F-MDMB-BINACA (5.69–7.39 nM). All six remain microgram-active full CB1 agonists vastly stronger and riskier than botanical Banana Haze flower.
Physicochemical Stability & Storage
Physical Form: White, yellow, brown, or tan neat powder or solid (NEVER supplied on sprayed herbs). · Soluble in chloroform, methanol, ethanol, DMF, and DMSO; only partially soluble in water.
Store sealed, dry, and protected from light in a cool or frozen container.
Cross-Tolerance & Dependence Profile
Dose- and duration-dependent physical dependence and rapid CB1 cross-tolerance across all cannabinoids; abrupt cessation after frequent use causes anxiety, insomnia, nausea, and sweating.
Codes on this card
Short meanings for the abbreviations printed with this substance.
DAT
Dopamine transporter
DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.
SERT
Serotonin transporter
SERT is the protein that collects serotonin back into the nerve cell. A higher number than at DAT means the serotonin transporter needed more concentration to reach the halfway point.
NMDA
NMDA glutamate channel
NMDA is a glutamate receptor that works like a gated channel. Ketamine-type and PCP-type cards cite it when papers describe that channel as blocked.
CB₁ / CB₂
Cannabinoid receptors CB1 and CB2
CB1 and CB2 are the two cannabinoid receptors named on these cards. Papers usually discuss CB1 in the nervous system and CB2 more often in immune tissue. The number beside them is often a Ki in nanomoles.
EC₅₀ / IC₅₀
Halfway concentration
EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.
Kᵢ
Binding tightness in nanomoles
Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.
ratio
Selectivity ratio
A selectivity ratio divides two halfway numbers, such as SERT EC50 by DAT EC50, to show which target the assay reached first. The direction of the division has to be stated, or the number flips.
5-HT ↑↑
Serotonergic Overload (Serotonin Toxicity)
A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.
Chemical Architecture & Structural Profile
MDMB-4en-PINACA (methyl (2S)-3,3-dimethyl-2-[(1-pent-4-enylindazole-3-carbonyl)amino]butanoate) is a reference compound belonging to the Cannabinoids (Indazole carboxamides) class, characterized by the molecular formula C20H27N3O3 and a molar mass of 357.4 g/mol. The parent molecule is indexed under CAS registry number 2504100-70-1 and in the NCBI PubChem database as CID 155804661 (Standard InChIKey: LWOCBHBFWNGPGM-QGZVFWFLSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), MDMB-4en-PINACA is indexed within the Cannabinoids (Indazole carboxamides) structural group. Synthetic indazole carboxamide exhibiting high receptor affinity in in-vitro assays; requires calibrated micro-analytical balances and full dermal and respiratory protection. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Riksdagen — Förordning (1999:58) om förbud mot vissa hälsofarliga varor — Sveriges riksdag (2026-11-12)